Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03526432
Title Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Oklahoma

endometrial carcinoma


Atezolizumab + Bevacizumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UAB Women and Infants Center Birmingham Alabama 35233 United States Details
Washington University School of Medicine Saint Louis Missouri 63108 United States Details
Stephenson Cancer Center, University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73117 United States Details
*Shaded cells indicate that there was no data available from for the field